$2.50
0.114.60%
At close: -
$2.39
-0.11-4.40%
After Hours: Dec 19, 4:09 PM EDT
VYNE Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of VYNE Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-07 | $-0.29 | $-0.23 | -26.1 % |
Jun 2024 | 2024-08-14 | $-0.22 | $-0.19 | -15.8 % |
Mar 2024 | 2024-05-09 | $-0.15 | $-0.24 | 37.5 % |
Dec 2023 | 2024-02-29 | $-0.18 | $-0.50 | 64.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-07 | $121.00K | $110.00K | 10.0 % |
Jun 2024 | 2024-08-14 | $198.00K | $110.00K | 80.0 % |
Mar 2024 | 2024-05-09 | $98.00K | $100.00K | -2.00 % |
Dec 2023 | 2024-02-29 | $76.00K | $150.00K | -49.3 % |
VYNE Therapeutics (VYNE) is scheduled to report earnings on February 27, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
The Actual EPS was $-0.29, which missed the estimate of $-0.23.
The Actual Revenue was $121K, which beat the estimate of $110K.
Browse earnings estimates, EPS, and revenue on all stocks.